|
OMIM |
Link |
Information gain |
01 |
|
eosinophilia, familial
|
[NCBI]
|
0.00396832
|
|
|
RNASE3
|
[NCBI]
|
0.00278595
|
|
|
esophagitis, eosinophilic
|
[NCBI]
|
0.00214559
|
|
|
enteropathy, protein-losing
|
[NCBI]
|
0.00106493
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000765046
|
|
|
HFA
|
[NCBI]
|
0.000711792
|
|
|
RNASE2
|
[NCBI]
|
0.000579043
|
|
|
omenn syndrome
|
[NCBI]
|
0.000546283
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.000375513
|
|
|
myeloproliferative disorder, chronic, with eosinophilia
|
[NCBI]
|
0.000213713
|
|
|
PDGFRB
|
[NCBI]
|
0.000191002
|
|
|
IL5
|
[NCBI]
|
0.000179521
|
|
|
HES
|
[NCBI]
|
0.000163608
|
|
|
SCN1
|
[NCBI]
|
0.000139414
|
|
|
IP
|
[NCBI]
|
0.000134678
|
|
|
combined inflammatory and immunologic defect
|
[NCBI]
|
0.000122157
|
|
|
eosinophilic fasciitis
|
[NCBI]
|
0.000122157
|
|
|
neutropenia, lethal congenital, with eosinophilia
|
[NCBI]
|
0.000122157
|
|
|
CCR3
|
[NCBI]
|
0.000103526
|
|
|
FIP1L1
|
[NCBI]
|
9.53665e-05
|
|
|
STAT6
|
[NCBI]
|
9.3792e-05
|
|
|
ALPS
|
[NCBI]
|
8.46964e-05
|
|
|
ZNF198
|
[NCBI]
|
8.33006e-05
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
8.16324e-05
|
|
|
FGFR1
|
[NCBI]
|
7.69808e-05
|
|
|
RCM1
|
[NCBI]
|
7.33559e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
6.95364e-05
|
|
|
PDE4DIP
|
[NCBI]
|
6.84398e-05
|
|
|
TRIP11
|
[NCBI]
|
6.84398e-05
|
|
|
CCL26
|
[NCBI]
|
6.84398e-05
|
|
|
CSF2
|
[NCBI]
|
6.55866e-05
|
|
|
KTCN1
|
[NCBI]
|
5.71567e-05
|
|
|
TCF7
|
[NCBI]
|
5.46692e-05
|
|
|
HNRPDL
|
[NCBI]
|
5.46692e-05
|
|
|
SPRED1
|
[NCBI]
|
5.46692e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
5.43009e-05
|
|
|
ASPS
|
[NCBI]
|
5.43009e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
5.30458e-05
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
5.18834e-05
|
|
|
EFE
|
[NCBI]
|
4.97884e-05
|
|
|
CLDN7
|
[NCBI]
|
4.94779e-05
|
|
|
LGMD2A
|
[NCBI]
|
4.79409e-05
|
|
|
IGER
|
[NCBI]
|
4.79409e-05
|
|
|
IL25
|
[NCBI]
|
4.61102e-05
|
|
|
PVALB
|
[NCBI]
|
4.61102e-05
|
|
|
CLC
|
[NCBI]
|
4.61102e-05
|
|
|
CCL11
|
[NCBI]
|
4.36086e-05
|
|
|
MPO
|
[NCBI]
|
4.31274e-05
|
|
|
CHIA
|
[NCBI]
|
4.16171e-05
|
|
|
HAE
|
[NCBI]
|
4.02161e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
3.77835e-05
|
|
|
RAG2
|
[NCBI]
|
3.73122e-05
|
|
|
C5R1
|
[NCBI]
|
3.73122e-05
|
|
|
LAT
|
[NCBI]
|
3.43351e-05
|
|
|
TLR7
|
[NCBI]
|
3.27606e-05
|
|
|
C5
|
[NCBI]
|
3.27606e-05
|
|
|
RAG1
|
[NCBI]
|
3.27606e-05
|
|
|
DBA
|
[NCBI]
|
2.91741e-05
|
|
|
NMU
|
[NCBI]
|
2.86778e-05
|
|
|
ETV6
|
[NCBI]
|
2.61862e-05
|
|
|
CMH
|
[NCBI]
|
2.58541e-05
|
|
|
IL3
|
[NCBI]
|
2.51505e-05
|
|
|
CAPN3
|
[NCBI]
|
2.51505e-05
|
|
|
SOCS3
|
[NCBI]
|
2.45186e-05
|
|
|
AQP1
|
[NCBI]
|
2.36447e-05
|
|
|
JAK3
|
[NCBI]
|
2.25947e-05
|
|
|
VEGF
|
[NCBI]
|
2.05409e-05
|
|
|
PJS
|
[NCBI]
|
2.04273e-05
|
|
|
AMACR
|
[NCBI]
|
2.04007e-05
|
|
|
DFSP
|
[NCBI]
|
1.94845e-05
|
|
|
CCL22
|
[NCBI]
|
1.93021e-05
|
|
|
CCL17
|
[NCBI]
|
1.7874e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.76431e-05
|
|
|
PTH
|
[NCBI]
|
1.6021e-05
|
|
|
ADM
|
[NCBI]
|
9.74529e-06
|
|
|
RA
|
[NCBI]
|
9.29777e-06
|
|
|
GJA1
|
[NCBI]
|
9.28766e-06
|
|
|
CF
|
[NCBI]
|
5.5516e-06
|
|
|
SLE
|
[NCBI]
|
5.54338e-06
|
|
|
NGFB
|
[NCBI]
|
5.04602e-06
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
4.99786e-06
|
|
|
PF4
|
[NCBI]
|
3.7889e-06
|
|
|
EGFR
|
[NCBI]
|
3.66475e-06
|
|
|
APOE
|
[NCBI]
|
3.10711e-06
|
|
|
PTK2
|
[NCBI]
|
2.16724e-06
|
|
|
MBP
|
[NCBI]
|
1.39393e-06
|
|
|
HGF
|
[NCBI]
|
1.18588e-06
|
|
|
TNF
|
[NCBI]
|
6.84323e-07
|
|
|
CFTR
|
[NCBI]
|
8.32363e-08
|
|